| Product Code: ETC13131384 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Middle East Non-Small Cell Lung Cancer Diagnostics Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Middle East Non-Small Cell Lung Cancer Diagnostics Market Overview |
3.1 Middle East Regional Macro Economic Indicators |
3.2 Middle East Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 Middle East Non-Small Cell Lung Cancer Diagnostics Market - Industry Life Cycle |
3.4 Middle East Non-Small Cell Lung Cancer Diagnostics Market - Porter's Five Forces |
3.5 Middle East Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Middle East Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.7 Middle East Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.8 Middle East Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume Share, By Test, 2021 & 2031F |
3.9 Middle East Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 Middle East Non-Small Cell Lung Cancer Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Middle East Non-Small Cell Lung Cancer Diagnostics Market Trends |
6 Middle East Non-Small Cell Lung Cancer Diagnostics Market, 2021 - 2031 |
6.1 Middle East Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Middle East Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Lung Adenocarcinoma (LUAD), 2021 - 2031 |
6.1.3 Middle East Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Lung Squamous Cell carcinoma (LUSC), 2021 - 2031 |
6.1.4 Middle East Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Large Cell Carcinoma, 2021 - 2031 |
6.1.5 Middle East Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 Middle East Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Product, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Middle East Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Reagents & Kits, 2021 - 2031 |
6.2.3 Middle East Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Instruments And Services & Software's, 2021 - 2031 |
6.3 Middle East Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Test, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Middle East Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Imaging Test, 2021 - 2031 |
6.3.3 Middle East Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Molecular Test, 2021 - 2031 |
6.3.4 Middle East Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Biopsy, 2021 - 2031 |
6.3.5 Middle East Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Sputum Cytology, 2021 - 2031 |
6.3.6 Middle East Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Thoracentesis, 2021 - 2031 |
6.3.7 Middle East Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Immunohistochemistry, 2021 - 2031 |
6.3.8 Middle East Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Others, 2021 - 2031 |
6.4 Middle East Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By End-User, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Middle East Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Hospital, 2021 - 2031 |
6.4.3 Middle East Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Clinical Laboratories, 2021 - 2031 |
6.4.4 Middle East Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Academics, 2021 - 2031 |
6.4.5 Middle East Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Others, 2021 - 2031 |
7 Middle East Non-Small Cell Lung Cancer Diagnostics Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Middle East Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
7.2.1 Saudi Arabia Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
7.2.2 UAE Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
7.2.3 Kuwait Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
7.2.4 Qatar Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
7.2.5 Bahrain Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
7.2.6 Oman Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
7.2.7 Turkey Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
7.2.8 Rest of Middle East Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
7.3 Middle East Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume Share, By Product, 2021 & 2031F |
7.3.1 Saudi Arabia Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Product, 2021 - 2031 |
7.3.2 UAE Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Product, 2021 - 2031 |
7.3.3 Kuwait Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Product, 2021 - 2031 |
7.3.4 Qatar Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Product, 2021 - 2031 |
7.3.5 Bahrain Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Product, 2021 - 2031 |
7.3.6 Oman Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Product, 2021 - 2031 |
7.3.7 Turkey Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Product, 2021 - 2031 |
7.3.8 Rest of Middle East Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Product, 2021 - 2031 |
7.4 Middle East Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Test, 2021 - 2031 |
7.4.1 Saudi Arabia Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Test, 2021 - 2031 |
7.4.2 UAE Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Test, 2021 - 2031 |
7.4.3 Kuwait Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Test, 2021 - 2031 |
7.4.4 Qatar Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Test, 2021 - 2031 |
7.4.5 Bahrain Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Test, 2021 - 2031 |
7.4.6 Oman Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Test, 2021 - 2031 |
7.4.7 Turkey Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Test, 2021 - 2031 |
7.4.8 Rest of Middle East Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Test, 2021 - 2031 |
7.5 Middle East Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By End-User, 2021 - 2031 |
7.5.1 Saudi Arabia Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By End-User, 2021 - 2031 |
7.5.2 UAE Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By End-User, 2021 - 2031 |
7.5.3 Kuwait Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By End-User, 2021 - 2031 |
7.5.4 Qatar Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By End-User, 2021 - 2031 |
7.5.5 Bahrain Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By End-User, 2021 - 2031 |
7.5.6 Oman Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By End-User, 2021 - 2031 |
7.5.7 Turkey Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By End-User, 2021 - 2031 |
7.5.8 Rest of Middle East Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By End-User, 2021 - 2031 |
8 Middle East Non-Small Cell Lung Cancer Diagnostics Market Key Performance Indicators |
9 Middle East Non-Small Cell Lung Cancer Diagnostics Market - Export/Import By Countries Assessment |
10 Middle East Non-Small Cell Lung Cancer Diagnostics Market - Opportunity Assessment |
10.1 Middle East Non-Small Cell Lung Cancer Diagnostics Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Middle East Non-Small Cell Lung Cancer Diagnostics Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
10.3 Middle East Non-Small Cell Lung Cancer Diagnostics Market Opportunity Assessment, By Product, 2021 & 2031F |
10.4 Middle East Non-Small Cell Lung Cancer Diagnostics Market Opportunity Assessment, By Test, 2021 & 2031F |
10.5 Middle East Non-Small Cell Lung Cancer Diagnostics Market Opportunity Assessment, By End-User, 2021 & 2031F |
11 Middle East Non-Small Cell Lung Cancer Diagnostics Market - Competitive Landscape |
11.1 Middle East Non-Small Cell Lung Cancer Diagnostics Market Revenue Share, By Companies, 2022 |
11.2 Middle East Non-Small Cell Lung Cancer Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |